| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/02/2011 | CN101965366A Immunoconjugates targeting cd138 and uses thereof |
| 02/02/2011 | CN101965365A Antibody capable of combining the soluble ass oligomer specifically and application thereof |
| 02/02/2011 | CN101965364A Antibody single variable domains against serum albumin |
| 02/02/2011 | CN101965363A Hybrid immunoglobulins with moving parts |
| 02/02/2011 | CN101965362A Novel antigen binding dimer-complexes, methods of making and uses thereof |
| 02/02/2011 | CN101963619A Method for quantifying and detecting recombinant protein containing green fluorescent protein fusion tag |
| 02/02/2011 | CN101962644A Method for preparing swine novel gene BCL-GL polyclonal antibody |
| 02/02/2011 | CN101962408A Super-humanized antibody |
| 02/02/2011 | CN101962407A Method for preparing anti-taxol monoclonal antibody |
| 02/02/2011 | CN101962406A Light chain and heavy chain variable regions of anti-SEB (Staphylococcal Enterotoxin B) monoclonal antibody FMU-SEB-No.2 with high affinity |
| 02/02/2011 | CN101962405A Humanized breast cancer antigen and antibody thereof |
| 02/02/2011 | CN101962368A Cyanurate hapten, artificial antigen and antibody, and preparation method and applications thereof |
| 02/02/2011 | CN101962358A Ciprofloxacin hapten, artificial antigen and antibody and preparation method and application thereof |
| 02/02/2011 | CN101962343A Hapten, artificial antigen and antibody of basic orange as well as preparation method and application thereof |
| 02/02/2011 | CN101961496A Cancerous disease modifying antibodies |
| 02/02/2011 | CN101961488A Method for preparing serum for resisting Muscovy duck parvovrius |
| 02/01/2011 | US7879990 Polynucleotides encoding antibodies that bind to the C35 polypeptide |
| 02/01/2011 | US7879988 Fluorescent proteins from Aequorea coerulscens and methods for using the same |
| 02/01/2011 | US7879987 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| 02/01/2011 | US7879985 Antibodies against human NKG2D and uses thereof |
| 02/01/2011 | US7879984 Human antibodies to human CD20 and method of using thereof |
| 02/01/2011 | US7879983 Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for treating cancer |
| 02/01/2011 | US7879982 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis |
| 02/01/2011 | US7879981 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 02/01/2011 | US7879980 Monoclonal antibodies to human CTLA-8 (IL-17A) |
| 02/01/2011 | US7879979 conjugated to protein, polypeptide, detectable label, nucleic acid, or solid phase, for generating antibodies that bind specifically with dimethylarginine, which can be detected using such antibodies in immunoassays |
| 02/01/2011 | US7879801 For therapy of cancer and viral infections |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879577 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879330 Monoclonal antibody for use in passive immunization against botulinum intoxication; immunotherapy |
| 02/01/2011 | US7879328 Antibodies that immunospecifically bind to B lymphocyte stimulator |
| 02/01/2011 | US7879327 Treating breast cancer via administration of trastuzumab and amrubicinol |
| 02/01/2011 | US7879326 Human neutralizing monoclonal antibodies to H5N1 influenza A virus |
| 02/01/2011 | US7879325 HER2 antibody composition |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879322 Compositions and methods for use for antibodies against sclerostin |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | CA2587617C Fc variants with altered binding to fcrn |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/27/2011 | WO2011011453A2 Phenotyping tumor-infiltrating leukocytes |
| 01/27/2011 | WO2011011027A1 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 01/27/2011 | WO2011010717A1 Anti-psk antibody |
| 01/27/2011 | WO2011010485A1 Process for production of eicosanoid, eicosanoid biosynthesis gene derived from marchantia polymorpha, and use of the gene |
| 01/27/2011 | WO2011009623A1 Optimizing the production of antibodies |
| 01/27/2011 | WO2011009173A1 Cancer immunotherapy |
| 01/27/2011 | WO2010141249A3 Generation, characterization and uses thereof of anti-notch3 antibodies |
| 01/27/2011 | WO2010130830A3 Anti-sclerostin vhh and their use for treating bone diseases |
| 01/27/2011 | WO2010130824A3 Collections and uses thereof |
| 01/27/2011 | WO2010125565A3 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder |
| 01/27/2011 | WO2010096434A3 Specific binding proteins and uses thereof |
| 01/27/2011 | US20110023186 Method for modifying plant morphology, biochemistry and physiology |
| 01/27/2011 | US20110023184 Axmi-205 pesticidal gene and methods for its use |
| 01/27/2011 | US20110023160 Functional Disruption Of Avian Immunoglobulin Genes |
| 01/27/2011 | US20110023135 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions |
| 01/27/2011 | US20110021759 Diagnosis and Treatment of Blood Disorders |
| 01/27/2011 | US20110021758 Hybrid antibodies |
| 01/27/2011 | US20110021757 Transgenic silkworm capable of producing antibody and method for production thereof |
| 01/27/2011 | US20110021756 Method of manufacturing an affinity particle, affinity particle, and separation method |
| 01/27/2011 | US20110021755 Optimized Fc Variants |
| 01/27/2011 | US20110021745 Ultra-small chitosan nanoparticles useful as bioimaging agents and methods of making same |
| 01/27/2011 | US20110021744 Process for preparing purified drug conjugates |
| 01/27/2011 | US20110021635 Rbm3 as a marker for breast cancer prognosis |
| 01/27/2011 | US20110021611 Efficient cell culture system for hepatitis c virus genotype 5a |
| 01/27/2011 | US20110021546 Gene Defects And Mutant ALK Kinase In Human Solid Tumors |
| 01/27/2011 | US20110021444 Compositions for controlling hair growth |
| 01/27/2011 | US20110021429 Renoprotection by growth hormone-releasing hormone and agonists |
| 01/27/2011 | US20110021412 Human Receptor Proteins; Related Reagents and Methods |
| 01/27/2011 | US20110021370 Salivary protein biomarkers for human oral cancer |
| 01/27/2011 | US20110020951 Purified sr-p70 protein |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020912 Method for the construction of randomized gene sequence libraries in cells |
| 01/27/2011 | US20110020848 Method for detection of pneumococcus |
| 01/27/2011 | US20110020845 Method for the detection and identification of a variant c. difficile strain in a sample |
| 01/27/2011 | US20110020800 Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use |
| 01/27/2011 | US20110020798 Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 01/27/2011 | US20110020403 immunizing composition |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
| 01/27/2011 | US20110020396 HIV Envelope-CD4 Complexes and Hybrids |
| 01/27/2011 | US20110020379 Cobalamin Assay |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020370 Slc7a5 directed diagnostics and therapeutics for neoplastic disease |
| 01/27/2011 | US20110020369 Engineered anti-tslpr antibodies |
| 01/27/2011 | US20110020368 Treating cancer by down-regulating frizzled-4 and/or frizzled-1 |
| 01/27/2011 | US20110020363 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13ralpha1) |
| 01/27/2011 | US20110020361 Human anti-mesothelin monoclonal antibodies |
| 01/27/2011 | US20110020360 Targeted binding agents directed to pdgrf-alpha and uses thereof |
| 01/27/2011 | US20110020358 Methods and Compositions for Detecting Amyotrophic Lateral Sclerosis |
| 01/27/2011 | US20110020357 Anti human immunodeficiency antibodies and uses thereof |
| 01/27/2011 | US20110020356 Therapeutic clostridium difficile antibody compositions |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020353 Antibodies and related molecules that bind to 161p2f10b proteins |